Dermatologic Adverse Event Mitigation and Management Strategies With Amivantamab + Lazertinib Therapy for Advanced Non-Small Cell Lung Cancer – A Vodcast

Article full text

The above vodcast represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2025